Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

7
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
7
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

9
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
9
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

15
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
15
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

23
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
23
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

476
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
476
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

3.6K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer Risk in Acromegaly: Reassessing the Evidence and Impact of Biochemical Control.

The Journal of clinical endocrinology and metabolism·2026
Same author

Impact of chronic cholecalciferol supplementation and vitamin D status on risk of post-vaccination SARS-CoV-2 breakthrough infection.

Endocrine·2026
Same author

GLP-1 Receptor Agonist Exposure and Malignancy Risk in Patients With Endogenous Cushing's Syndrome.

The Journal of clinical endocrinology and metabolism·2026
Same author

Increased risk of atrial fibrillation and flutter in patients with Cushing's syndrome: a population-based matched cohort study.

European journal of endocrinology·2026
Same author

Consensus on acromegaly complications: an update.

Pituitary·2026
Same author

Chronic cholecalciferol supplementation and adequate vitamin D status are associated with reduced risk of Long COVID.

Journal of endocrinological investigation·2026
Same journal

Approach to Personalizing the Treatment of Osteoporosis.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Machine Learning Algorithms to Accelerate Etiological Diagnosis of Congenital Disorders of Adrenal Steroidogenesis.

The Journal of clinical endocrinology and metabolism·2026
Same journal

The Evolution and Validation of Thyroid Cancer Guidelines as Evidence Advances Toward Individualized Therapy.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Safety and Efficacy of Once-Daily Oral Paltusotine in Acromegaly: ACROBAT Advance Open-Label Extension Up to 4 Years.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Low Serum Testosterone Concentrations Predict Incident Frailty in Men with HIV.

The Journal of clinical endocrinology and metabolism·2026
Same journal

An Integrated Approach to Reclassify MEN1 Variants of Uncertain Significance Using Clinical and Computational Evidence.

The Journal of clinical endocrinology and metabolism·2026
See all related articles

Related Experiment Video

Updated: Apr 23, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

18.5K

Acromegaly complications: an update.

Andrea Giustina1, Maria Fleseriu2

  • 1Institute of Endocrine and Metabolic Sciences, San Raffaele Vita-Salute University and IRCCS San Raffaele Hospital, Milan 20132, Italy.

The Journal of Clinical Endocrinology and Metabolism
|April 21, 2026
PubMed
Summary
This summary is machine-generated.

Managing acromegaly requires understanding its common comorbidities, such as cardiorespiratory, metabolic, bone, and oncologic issues. Individualized treatment of these complications is crucial for improving patient quality of life and survival.

Keywords:
acromegalycancercardiomyopathydiabetes mellitushypertensionvertebral fractures

More Related Videos

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion
05:30

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion

Published on: February 14, 2025

1.8K
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
09:53

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on: July 5, 2021

3.3K

Related Experiment Videos

Last Updated: Apr 23, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

18.5K
Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion
05:30

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion

Published on: February 14, 2025

1.8K
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
09:53

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on: July 5, 2021

3.3K

Area of Science:

  • Endocrinology
  • Internal Medicine

Background:

  • Acromegaly significantly impacts quality of life and survival due to associated comorbidities.
  • Effective management of acromegaly necessitates a thorough understanding and treatment of these complications.

Purpose of the Study:

  • To review the pathophysiology, diagnosis, and clinical presentation of acromegaly complications.
  • To evaluate the impact of acromegaly therapy on comorbidities and outline current treatment goals.

Main Methods:

  • Comprehensive literature review on acromegaly comorbidities.
  • Analysis of current therapeutic impacts and treatment outcome goals.

Main Results:

  • Focus on key comorbidities: cardiorespiratory, metabolic, bone, and oncologic.
  • Evaluation of complications influencing pharmacologic treatment decisions.

Conclusions:

  • Individualized management of acromegaly comorbidities is essential.
  • Understanding these complications aids in optimizing patient care and treatment strategies.